BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Fennec Provides Business Update And Reports Third Quarter 2017 Results

  Cash and cash equivalents were $9,688 at September 30, 2017 and $3,926 at December 31, 2016.

  November 13, 2017

   · 

  10 min read
• Drug Development

  NANOBIOTIX Presented New Clinical and Pre-Clinical Data Confirming NBTXR3’s Significant Potential Role in Immuno-Oncology at SITC Annual Meeting

  Nanobiotix’s lead product, NBTXR3, has a universal physical mode of action which is designed for the local destruction of tumors.

  November 13, 2017

   · 

  8 min read
• Business

  Xbrane Biopharma Releases Interim Report for the Period July to September 2017

  nterim report for the period July - September 2017 is now available on the company’s website.

  November 13, 2017

   · 

  1 min read